tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Myles Minter, 2 are a BUY (100%).
Analyst Myles Minter works at WILLIAM BLAIR with a stock forecast success ratio of 50% fulfilled within 3.5 days on average.
Myles Minter’s has documented 8 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KRTX, Karuna Therapeutics at 13-Jul-2023.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 1/14/2020. The price target of $105 was fulfilled within 7 days with a profit of $20.13 (23.72%) receiving and performance score of 33.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
15
$9.19 (158.18%)
8
4 months 1 days ago
1/4 (25%)
$7 (87.50%)
128
Buy
9
$3.19 (54.91%)
10
4 months 29 days ago
1/5 (20%)
$4.69 (108.82%)
24
Sell
4
$-1.81 (-31.15%)
9
6 months 21 days ago
2/2 (100%)
$-2.98 (-42.69%)
36
Hold
10
$4.19 (72.12%)
10
8 months 8 days ago
1/5 (20%)
$2.64 (35.87%)
332
Buy
41
$35.19 (605.68%)
41
8 months 11 days ago
0/4 (0%)
$32.23 (367.50%)
What Year was the first public recommendation made by Myles Minter?
